Concepedia

Katharina Rothe

KR

Statistics

Publications

14

Citations

796

H-Index

13

Active since

2011

Affiliations

University of British Columbia(Current)

Terry Fox Research Institute

BC Cancer Agency

Canada's Michael Smith Genome Sciences Centre

Leukemia & Lymphoma Society of Canada

Katharina Rothe is an author at University of British Columbia specializing in oncology, molecular oncology, and life sciences.

ORCID

Publications per year

2011–2022

14

Publications

14

The core autophagy protein ATG4B is a potential biomarker and therapeutic target in CML stem/progenitor cells

Katharina Rothe, Hanyang Lin, Kevin B.L. Lin et al. · Blood · 2014 · 199 citations

, , +17

Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules

Gerard A. Silvestri, Nichole T. Tanner, Paul Kearney et al. · CHEST Journal · 2018 · 163 citations · Full text

, , +17

Loss of m1acp3Ψ Ribosomal RNA Modification Is a Major Feature of Cancer

Artem Babaian, Katharina Rothe, Dylan Girodat et al. · Cell Reports · 2020 · 110 citations · Full text

, , +17

The miR-185/PAK6 axis predicts therapy response and regulates survival of drug-resistant leukemic stem cells in CML

Hanyang Lin, Katharina Rothe, Min Chen et al. · Blood · 2020 · 56 citations · Full text

, , +16

Integrin-Linked Kinase Mediates Therapeutic Resistance of Quiescent CML Stem Cells to Tyrosine Kinase Inhibitors

Katharina Rothe, Artem Babaian, Naoto Nakamichi et al. · Cell stem cell · 2020 · 47 citations · Full text

, , +16

1–5 of 14